Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

GPR162 activates STING dependent DNA damage pathway as a novel tumor suppressor and radiation sensitizer
Yao Long, Jiaxing Guo, Jielin Chen, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 22

Showing 22 citing articles:

An Immunocompetent Hafnium Oxide-Based STING Nanoagonist for Cancer Radio-immunotherapy
Yuhua Cao, Shuaishuai Ding, Yunping Hu, et al.
ACS Nano (2024) Vol. 18, Iss. 5, pp. 4189-4204
Closed Access | Times Cited: 27
Decomposable Nanoagonists Enable NIR‐Elicited cGAS‐STING Activation for Tandem‐Amplified Photodynamic‐Metalloimmunotherapy
Xun Guo, Peng Tu, Xiaoting Wang, et al.
Advanced Materials (2024) Vol. 36, Iss. 21
Closed Access | Times Cited: 25
The multiple roles of interferon regulatory factor family in health and disease
Luyao Wang, Yanghui Zhu, Nan Zhang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Disulfidptosis-related signature predicts prognosis and characterizes the immune microenvironment in hepatocellular carcinoma
Jun Tang, Xintong Peng, Desheng Xiao, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 9
New insight in immunotherapy and combine therapy in colorectal cancer
Kai Ji, Hang Jia, Zixuan Liu, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access | Times Cited: 1
Advanced nanomaterials targeting activation of STING for enhanced cancer immunotherapy
Jia Tan, Meifang Wang, Binbin Ding, et al.
Coordination Chemistry Reviews (2023) Vol. 493, pp. 215316-215316
Closed Access | Times Cited: 17
The dark sides of the GPCR tree ‐ research progress on understudied GPCRs
Magdalena M. Scharf, Laura J. Humphrys, Sandra Berndt, et al.
British Journal of Pharmacology (2024)
Open Access | Times Cited: 6
Altered gene expression profiling by non-thermal plasma-activated media treatment in radioresistant head and neck squamous cell carcinoma
Sicong Zheng, Yudan Piao, Seung-Nam Jung, et al.
Clinical and Experimental Otorhinolaryngology (2025)
Open Access
A stimuli-responsive immunostimulant to activate chemo-immunotherapeutic effects by inducing DNA damage and STING activation
Shuiying Zhang, Hangyu Zhou, Yixin Liu, et al.
Journal of Colloid and Interface Science (2025) Vol. 688, pp. 664-676
Closed Access
Potential role of lactylation in intrinsic immune pathways in lung cancer
Mengdie Huang, Ye Jin, Dandan Zhao, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Novel Intravenous Formulation for Radiosensitization in Osteosarcoma Treatment
Haitao Zeng, Huixiong Feng, Chong Zhang, et al.
Materials Today Bio (2025) Vol. 32, pp. 101682-101682
Open Access
A Metformin-Based Multifunctional Nanoplatform as a DNA Damage Amplifier for Maximized Radio-Immunotherapy to Overcome Radiotherapy Resistance
Shuangyan He, Yun Huang, Jia Liu, et al.
ACS Nano (2025)
Closed Access
Dual Facets of Ionizing Radiation in Cancer Therapy: Immunomodulation and Immunosuppression
Ao Sun, Xu Huai, Wenjing Tao, et al.
(2025), pp. 233-262
Closed Access
Bibliometric analysis of ferroptosis: a comprehensive evaluation of its contribution to lung cancer
Feifei Yao, Feng Guo, Chengyi Sun, et al.
Frontiers in Genetics (2025) Vol. 15
Open Access
Multi‐omics integration reveals the oncogenic role of eccDNAs in diffuse large B‐cell lymphoma through STING signalling
Zijuan Wu, Wei Zhang, Luqiao Wang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 8
Open Access | Times Cited: 2
Mechanism of action and treatment of type I interferon in hepatocellular carcinoma
Chunxiu Peng, Zhijian Ye, Ying Ju, et al.
Clinical & Translational Oncology (2023) Vol. 26, Iss. 2, pp. 326-337
Closed Access | Times Cited: 6
The DNA damage and regulatory strategy in hematopoietic stem cells after irradiation exposure: Progress and challenges
Yanying Liu, Naicheng Chen, Fang Chen, et al.
Radiation Medicine and Protection (2023) Vol. 5, Iss. 1, pp. 16-23
Open Access | Times Cited: 3
Deciphering disulfidptosis: Uncovering a lncRNA-based signature for prognostic assessment, personalized immunotherapy, and therapeutic agent selection in lung adenocarcinoma patients
Chao Ma, Huan Zhao, Yang Sun, et al.
Cellular Signalling (2024) Vol. 117, pp. 111105-111105
Closed Access
Astragalus Polysaccharide Mitigates Rhabdomyolysis-Induced Acute Kidney Injury by Inhibiting M1 Polarization of Macrophages
Shiping Zhu, Chuanchuan Sun, Xinhai Zhao, et al.
(2024)
Closed Access
Manganese improves CD8+ T cell recruitment via cGAS-STING in hepatocellular carcinoma
Chenchen Fu, Hanrui Guo, Meiling Wang, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113591-113591
Closed Access
Astragalus Polysaccharide Mitigates Rhabdomyolysis-Induced Acute Kidney Injury via Inhibition of M1 Macrophage Polarization and the cGAS-STING Pathway
Chuanchuan Sun, Xinhai Zhao, Xianghong Wang, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 11505-11527
Open Access
LncRNA MALAT1 facilitates BM-MSCs differentiation into endothelial cells and ameliorates erectile dysfunction via the miR-206/CDC42/PAK1/paxillin signalling axis
Longhua Luo, Zixin Wang, Xuxian Tong, et al.
Reproductive Biology and Endocrinology (2024) Vol. 22, Iss. 1
Open Access
Author Correction: GPR162 activates STING dependent DNA damage pathway as a novel tumor suppressor and radiation sensitizer
Yao Long, Jiaxing Guo, Jielin Chen, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 1
GPR162 is a beta cell CART receptor
Andreas Lindqvist, Mia Abels, Liliya Shcherbina, et al.
iScience (2023) Vol. 26, Iss. 12, pp. 108416-108416
Open Access | Times Cited: 1
Page 1

Scroll to top